ISPOR 2026 Home
  • About
    • News Center
  • Program
    • Program
    • Posters
    • Student Program
    • Learning Formats
    • Program Committee
    • Plenary Sessions
  • Exhibits & Sponsorship
    • Exhibitor Directory
    • Sponsors
    • Media Partners
  • Photo Gallery
large-circle

ISPOR 2026

Sunday, May 17 - Wednesday, May 20

  • Home
  • Events
  • Past Conferences
  • ISPOR 2026
  • Program
  • Program
  • Presentation
  • ASSESSING THE VALIDITY AND RELIABILITY OF LATENT CLASS ANALYSES ON A POLICY-RELEVANT CHOICE EXPERIMENT ON HIV MOLECULAR EPIDEMIOLOGY

    Mar 18, 2026, 21:38 PM
  • ASSOCIATIONS OF SOCIODEMOGRAPHIC AND CLINICAL FACTORS WITH GLP-1 RECEPTOR AGONIST UTILIZATION AMONG U.S. ADULTS WITH DIABETES, A CROSS-SECTIONAL ANALYSIS OF 2024 NHIS DATA

    Mar 18, 2026, 21:38 PM
  • INCREMENTAL HEALTHCARE COSTS ASSOCIATED WITH DECOMPENSATION EVENTS AMONG PATIENTS WITH CIRRHOSIS IN THE UNITED STATES

    Mar 18, 2026, 21:38 PM
  • ORGANIZATIONAL AND BUDGET IMPACT MODEL (OBIM) OF A NATIONAL SCREENING PROGRAM FOR PRECLINICAL TYPE 1 DIABETES (T1D) IN FRANCE

    Mar 18, 2026, 21:38 PM
  • INFLATION REDUCTION ACT NEGOTIATIONS: QUALITATIVE INSIGHTS FROM 25 PART D DRUG PRICE NEGOTIATIONS

    Mar 18, 2026, 21:38 PM
  • METHODOLOGICAL COMPARISON OF CATEGORIZED VERSUS CONTINUOUS DECLINE IN KIDNEY FUNCTION: INSIGHTS FROM THE CKD CARE MODEL

    Mar 18, 2026, 21:38 PM
  • DISTRESS THERMOMETER SCORES AND OUTCOMES IN METASTATIC BREAST, COLORECTAL, AND LUNG CANCER: REAL-WORLD EVIDENCE FROM A LARGE US COMMUNITY ONCOLOGY SETTING

    Mar 18, 2026, 21:38 PM
  • UTILITY DATA IN HEALTH TECHNOLOGY ASSESSMENTS IN THE UNITED KINGDOM BY THE NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE

    Mar 18, 2026, 21:38 PM
  • EFFECTS OF FULL AUTOMATION IN WHOLE BLOOD PROCESSING ON OPERATOR SAFETY, ERGONOMIC PERFORMANCE AND WORKFLOW EFFICIENCY

    Mar 18, 2026, 21:38 PM
  • INCORPORATING REAL OPTION VALUE IN THE ECONOMIC EVALUATION OF OSIMERTINIB FOR ADVANCED EGFR-MUTATED NON-SMALL CELL LUNG CANCER

    Mar 18, 2026, 21:38 PM
  • COST EFFECTIVENESS ANALYSIS OF SONPIRETIGENE ISTEPARVOVEC FOR RETINITIS PIGMENTOSA WITH SEVERE VISION LOSS

    Mar 18, 2026, 21:38 PM
  • TREATMENT PERSISTENCE OF FIRST-LINE ADVANCED THERAPIES IN OLDER ADULTS WITH ULCERATIVE COLITIS USING US CLAIMS DATA

    Mar 18, 2026, 21:38 PM
  • PERIOPERATIVE COST-EFFECTIVENESS OF PARTIAL NEPHRECTOMY TECHNIQUES FOR RENAL CELL CARCINOMA IN THE UNITED STATES

    Mar 18, 2026, 21:38 PM
  • TREATMENT COMPARISON FOR HTA. USING NICE AS AN EXAMPLE, DOES CURRENT USE REFLECT THE EVOLUTION FROM ANCHORED METHODS TO COMPLEX MODELS, AND ADJUSTMENT TECHNIQUES?

    Mar 18, 2026, 21:38 PM
  • A METHODOLOGICAL COMPARISON OF THREE LANDMARKING APPROACHES FOR TIME-TO-EVENT PREDICTION: PREDICTING DIAGNOSED CANNABIS USE DISORDER AMONG MEDICAL MARIJUANA CARDHOLDERS IN ARKANSAS

    Mar 18, 2026, 21:38 PM
  • ROBOTIC-ASSISTED NIPPLE-SPARING MASTECTOMY WITH THE DA VINCI SURGICAL SYSTEM COMPARED TO OPEN SURGERY: A SYSTEMATIC LITERATURE REVIEW AND META-ANALYSIS

    Mar 18, 2026, 21:38 PM
  • CHANGES IN BREAST CANCER SCREENING PREVALENCE FOLLOWING UPDATED USPSTF MAMMOGRAPHY GUIDELINES: DESCRIPTIVE ANALYSIS USING MARKETSCAN TREATMENT PATHWAYS

    Mar 18, 2026, 21:38 PM
  • PHYSICAL AND MENTAL HEALTH STATUS AND PRODUCTIVITY LOSS ASSOCIATED WITH MIGRAINE: A REAL-WORLD EVIDENCE ANALYSIS USING A NATIONALLY REPRESENTATIVE US COHORT

    Mar 18, 2026, 21:38 PM
  • SYSTEMATIC LITERATURE REVIEW OF LIMITATIONS IN THE HYPOTHYROIDISM TREATMENT PARADIGM: CHALLENGES TO STABLE CONTROL AND QUALITY OF LIFE

    Mar 18, 2026, 21:38 PM
  • LONG-TERM OUTCOMES OF FIBROMYALGIA PATIENTS WITH AND WITHOUT INSOMNIA: A REAL-WORLD COHORT STUDY

    Mar 18, 2026, 21:38 PM
  • 1
  • 2
  • 3 (current)
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • »
Quick Links

  • About
  • Media Center
  • Exhibits & Sponsorships
  • Contact Us
Policies & Legal

  • Antitrust Compliance
  • Code of Ethics
  • Diversity Policy
  • Funding Statement
  • Legal Disclaimer
  • Privacy Policy

Subscribe

Join ISPOR


ISPOR–The Professional Society for
Health Economics and Outcomes Research

Copyright © 2018 ISPOR. All rights reserved.

International Society for Pharmacoeconomics and Outcomes Research, Inc

Website Design & Development by Matrix Group